Get started
III

IRLAB THERAPEUTICS AB SER. A

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

IRLAB_A chart


Full chart

IRLAB_A upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪731.34 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.15 SEK
Net income (FY)
‪−177.84 M‬ SEK
Revenue (FY)
‪5.68 M‬ SEK
Shares float
‪35.74 M‬
Beta (1Y)
−1.01

Employees


Employees (FY)
37
Change (1Y)
+4 +12.12%
Revenue / Employee (1Y)
‪15.15 K‬ SEK
Net income / Employee (1Y)
‪−474.40 K‬ SEK

About IRLAB THERAPEUTICS AB SER. A


Sector
Health Technology
CEO
Kristina Torfgård
Headquarters
Gothenburg
Website
irlab.se
Founded
2013
ISIN
SE0012675361
FIGI
BBG00G3F2C80
IRLAB Therapeutics AB engages in the provision of novel treatments for disorders of the brain that focuses on illness in the central nervous system. The fim develops drugs for Parkinson's disease. It also offers IRL752 that targets dementia in Parkinson's disease. The company was founded in 2013 and is headquartered in Gothenburg, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

IRLAB_A news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of IRLAB_A is 13.95 SEK — it has decreased by −2.13% in the past 24 hours. Watch IRLAB THERAPEUTICS AB SER. A stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange IRLAB THERAPEUTICS AB SER. A stocks are traded under the ticker IRLAB_A.
IRLAB_A stock has fallen by −1.43% compared to the previous week, the month change is a 16.95% rise, over the last year IRLAB THERAPEUTICS AB SER. A has showed a 110.09% increase.
We've gathered analysts' opinions on IRLAB THERAPEUTICS AB SER. A future price: according to them, IRLAB_A price has a max estimate of 40.00 SEK and a min estimate of 40.00 SEK. Watch IRLAB_A chart and read a more detailed IRLAB THERAPEUTICS AB SER. A stock forecast: see what analysts think of IRLAB THERAPEUTICS AB SER. A and suggest that you do with its stocks.
IRLAB_A reached its all-time high on Jul 10, 2019 with the price of 108.10 SEK, and its all-time low was 5.60 SEK and was reached on Dec 11, 2023. View more price dynamics on IRLAB_A chart.
See other stocks reaching their highest and lowest prices.
IRLAB_A stock is 3.68% volatile and has beta coefficient of −1.01. Track IRLAB THERAPEUTICS AB SER. A stock price on the chart and check out the list of the most volatile stocks — is IRLAB THERAPEUTICS AB SER. A there?
Today IRLAB THERAPEUTICS AB SER. A has the market capitalization of ‪715.78 M‬, it has increased by 2.17% over the last week.
Yes, you can track IRLAB THERAPEUTICS AB SER. A financials in yearly and quarterly reports right on TradingView.
IRLAB THERAPEUTICS AB SER. A is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
IRLAB_A net income for the last quarter is ‪−31.66 M‬ SEK, while the quarter before that showed ‪−7.06 M‬ SEK of net income which accounts for −348.60% change. Track more IRLAB THERAPEUTICS AB SER. A financial stats to get the full picture.
No, IRLAB_A doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2024, the company has 37.00 employees. See our rating of the largest employees — is IRLAB THERAPEUTICS AB SER. A on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IRLAB THERAPEUTICS AB SER. A EBITDA is ‪−114.64 M‬ SEK, and current EBITDA margin is ‪−3.10 K‬%. See more stats in IRLAB THERAPEUTICS AB SER. A financial statements.
Like other stocks, IRLAB_A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IRLAB THERAPEUTICS AB SER. A stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IRLAB THERAPEUTICS AB SER. A technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IRLAB THERAPEUTICS AB SER. A stock shows the neutral signal. See more of IRLAB THERAPEUTICS AB SER. A technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.